CARIBAN 10 mg/10 mg, modified-release capsule 24 capsules
Active ingredients: Pyridoxine hydrochloride, Doxylamine succinate
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release capsule24 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARIBAN 10 mg/10 mg, gélule à libération modifiée
- Pharmaceutical form
- gélule à libération modifiée
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) PVC PVDC aluminium de 12 gélule(s)
- Marketing authorisation holder
- EFFIK
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Oct 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61447165CIP73020838CIP133400930208380Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE DOXYLAMINEgélule | 10 mg · une gélule | SA |
| CHLORHYDRATE DE PYRIDOXINEgélule | 10 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.